Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Genetics

Can You Get FSHD Without a Family History?

At a Glance

Yes, you can get facioscapulohumeral dystrophy (FSHD) without a family history. Up to 30% of patients are the first in their family to have it, usually due to a spontaneous genetic change called a de novo mutation. Even without a family history, you can still pass the gene to your children.

Yes, you can absolutely develop facioscapulohumeral dystrophy (FSHD) even if no one else in your family has it. In fact, between 10% and 30% of all people diagnosed with FSHD have no documented family history of the disease [1][2].

When someone is the first in their family to be diagnosed with a genetic condition like FSHD, it is usually the result of a spontaneous genetic change, which doctors call a de novo mutation.

How Spontaneous (De Novo) Mutations Happen

Our bodies are constantly building and copying DNA. Sometimes, during the formation of an egg or sperm cell, or very shortly after an egg is fertilized, a copying error occurs.

In the case of FSHD, this usually means a specific section of DNA on chromosome 4 (called the D4Z4 repeat array) becomes unexpectedly shortened, or “contracted” [3]. This contraction is the hallmark of FSHD type 1 (FSHD1) and leads to the inappropriate activation of a gene called DUX4, which causes muscle damage [4]. Less commonly, a spontaneous mutation can occur in a different gene, such as SMCHD1, which causes FSHD type 2 (FSHD2) [5].

If these acronyms feel overwhelming, don’t panic. You can look at your genetic test results or ask your doctor to clarify exactly which type you have, as this helps map out your specific condition. Notably, some research suggests that spontaneous (de novo) mutations—particularly in FSHD1—can sometimes lead to symptoms starting earlier or varying in severity compared to inherited cases [6][7].

If you have a de novo mutation, you did not inherit the disease from your parents in the traditional sense; the genetic change started with you.

The Role of Mosaicism in Parents

In some cases where there appears to be no family history, one of the parents may actually carry the genetic change, but only in a small percentage of their cells. This phenomenon is called mosaicism [8].

Because the mutation is only present in a fraction of their body cells, the parent usually does not have any muscle weakness or symptoms of FSHD. However, if the genetic change is also present in their reproductive cells (sperm or eggs), they can pass the fully developed mutation to their child [9].

If your parents are considering having more children, or if you have healthy siblings who are planning families, they may want to speak with a genetic counselor. Highly sensitive genetic testing can determine if either of your parents has low-level mosaicism, which can help assess the risk for your siblings [10][8].

Passing the Gene to Future Children

It can be confusing to realize that you are the first person in your family to have a genetic disease, but you can still pass it down to the next generation.

Once a spontaneous mutation happens early in your development, it becomes a permanent part of your genetic blueprint. For the most common form of the disease (FSHD1), the condition is autosomal dominant. This means it only takes one copy of the altered gene to cause the disease [4][11]. Because you have one affected chromosome and one unaffected chromosome, there is a 50% chance with each pregnancy that you will pass the FSHD1 gene to your child [12]. (FSHD2 inheritance is a bit more complex, often requiring two specific genetic factors to align).

If you are thinking about starting or expanding your family, meeting with a genetic counselor can be incredibly helpful. They can discuss reproductive options with you, including specialized prenatal testing or in vitro fertilization (IVF) techniques that screen embryos for the FSHD gene before pregnancy [13][14].

Common questions in this guide

Can I have FSHD if my parents do not have it?
Yes, between 10 and 30 percent of people diagnosed with FSHD have no family history of the disease. This typically happens because of a new, spontaneous genetic change that starts with you rather than being passed down.
What does it mean if my FSHD is caused by a de novo mutation?
A de novo mutation is a spontaneous genetic change that occurs very early in your development. It means you did not inherit the condition from your parents in the traditional way, but the genetic change is now a permanent part of your DNA.
Could my healthy parents be carrying the FSHD gene without knowing it?
Yes, in some cases a parent might carry the genetic change in only a small fraction of their cells, which is called mosaicism. Because it is only in some cells, they do not have symptoms but can still pass the fully developed condition to their children.
Will I pass FSHD to my children if I am the first in my family to have it?
Yes, once a spontaneous genetic change happens to you, it becomes a permanent part of your genetic blueprint. For the most common type of the condition, there is a 50 percent chance of passing it to each of your children.
What are my options to avoid passing FSHD to my baby?
A genetic counselor can discuss various family planning options with you to reduce this risk. These include specialized prenatal testing or in vitro fertilization techniques that can screen embryos for the genetic change before a pregnancy begins.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.According to my genetic test results, do I have FSHD1 or FSHD2, and what was the specific genetic change?
  2. 2.Should my parents be tested for mosaicism to help us understand the risk for my healthy siblings?
  3. 3.Based on my specific de novo mutation, is there anything we should know about how my symptoms might progress compared to inherited cases?
  4. 4.What are my options for family planning if I want to minimize the chance of passing the FSHD gene to my future children?
  5. 5.Can you refer me to a genetic counselor to review these results in more detail?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Characterization of D4Z4 alleles and assessment of de novo cases in Facioscapulohumeral dystrophy (FSHD) in a cohort of Italian families.

    Strafella C, Colantoni L, Megalizzi D, et al.

    Clinical genetics 2024; (105(3)):335-339 doi:10.1111/cge.14466.

    PMID: 38041579
  2. 2

    Subclinical myocardial injury in patients with Facioscapulohumeral muscular dystrophy 1 and preserved ejection fraction - assessment by cardiovascular magnetic resonance.

    Blaszczyk E, Grieben U, von Knobelsdorff-Brenkenhoff F, et al.

    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance 2019; (21(1)):25 doi:10.1186/s12968-019-0537-4.

    PMID: 31030674
  3. 3

    Case report: Identification of facioscapulohumeral muscular dystrophy 1 in two siblings with normal phenotypic parents using optical genome mapping.

    Jiang J, Cai X, Qu H, et al.

    Frontiers in neurology 2024; (15()):1258831 doi:10.3389/fneur.2024.1258831.

    PMID: 38361638
  4. 4

    Inflammatory facioscapulohumeral muscular dystrophy type 2 in 18p deletion syndrome.

    Renard D, Taieb G, Garibaldi M, et al.

    American journal of medical genetics. Part A 2018; (176(8)):1760-1763 doi:10.1002/ajmg.a.38843.

    PMID: 30055030
  5. 5

    Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2.

    Lemmers RJ, Tawil R, Petek LM, et al.

    Nature genetics 2012; (44(12)):1370-4 doi:10.1038/ng.2454.

    PMID: 23143600
  6. 6

    Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.

    Nikolic A, Ricci G, Sera F, et al.

    BMJ open 2016; (6(1)):e007798 doi:10.1136/bmjopen-2015-007798.

    PMID: 26733561
  7. 7

    A pediatric case report and literature review of facioscapulohumeral muscular dystrophy type1.

    Xiao T, Yang H, Gan S, Wu L

    Medicine 2021; (100(47)):e27907 doi:10.1097/MD.0000000000027907.

    PMID: 34964760
  8. 8

    Optical genome mapping reveals maternal mosaicism in two Sibling cases of Early-Onset Facioscapulohumeral muscular dystrophy type 1.

    Liu C, Dong R, Shi B, et al.

    Clinica chimica acta; international journal of clinical chemistry 2025; (566()):120062 doi:10.1016/j.cca.2024.120062.

    PMID: 39603552
  9. 9

    Generation of genetically matched hiPSC lines from two mosaic facioscapulohumeral dystrophy type 1 patients.

    van der Wal E, den Hamer B, van der Vliet PJ, et al.

    Stem cell research 2019; (40()):101560 doi:10.1016/j.scr.2019.101560.

    PMID: 31518905
  10. 10

    Clinical Application of Optical Genome Mapping for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy.

    Shim Y, Seo J, Lee ST, et al.

    Annals of laboratory medicine 2024; (44(5)):437-445 doi:10.3343/alm.2023.0437.

    PMID: 38724225
  11. 11

    Integrating clinical and genetic observations in facioscapulohumeral muscular dystrophy.

    Mul K, van den Boogaard ML, van der Maarel SM, van Engelen BG

    Current opinion in neurology 2016; (29(5)):606-13 doi:10.1097/WCO.0000000000000360.

    PMID: 27389814
  12. 12

    Hereditary Neuromuscular Disorders in Reproductive Medicine.

    Luglio A, Maggi E, Riviello FN, et al.

    Genes 2024; (15(11)) doi:10.3390/genes15111409.

    PMID: 39596609
  13. 13

    Counseling and prenatal diagnosis in facioscapulohumeral muscular dystrophy: A retrospective study on a 13-year multidisciplinary approach.

    Di Feo MF, Bettio C, Salsi V, et al.

    Health science reports 2022; (5(3)):e614 doi:10.1002/hsr2.614.

    PMID: 35509380
  14. 14

    Road to conception and successful delivery for a facioscapulohumeral muscular dystrophy patient.

    Triantafyllidou O, Stavridis K, Kastora SL, Vlahos N

    SAGE open medical case reports 2022; (10()):2050313X221081359 doi:10.1177/2050313X221081359.

    PMID: 35251661

This page provides educational information about the genetics and inheritance of FSHD. It does not replace professional medical advice, genetic counseling, or formal diagnostic testing.

Get notified when new evidence is published on Facioscapulohumeral dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.